These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30852423)

  • 1. Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice.
    Shamskhou EA; Kratochvil MJ; Orcholski ME; Nagy N; Kaber G; Steen E; Balaji S; Yuan K; Keswani S; Danielson B; Gao M; Medina C; Nathan A; Chakraborty A; Bollyky PL; De Jesus Perez VA
    Biomaterials; 2019 May; 203():52-62. PubMed ID: 30852423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
    Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.
    Nakagome K; Dohi M; Okunishi K; Tanaka R; Miyazaki J; Yamamoto K
    Thorax; 2006 Oct; 61(10):886-94. PubMed ID: 16809410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.
    Soranno DE; Rodell CB; Altmann C; Duplantis J; Andres-Hernando A; Burdick JA; Faubel S
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F362-72. PubMed ID: 26962109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
    Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
    Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
    Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Kishi M; Aono Y; Sato S; Koyama K; Azuma M; Abe S; Kawano H; Kishi J; Toyoda Y; Okazaki H; Ogawa H; Uehara H; Nishioka Y
    PLoS One; 2018; 13(12):e0209786. PubMed ID: 30596712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
    Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
    He F; Zhou A; Feng S
    PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
    Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
    Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
    Li Y; Gao Q; Xu K; Peng X; Yuan X; Jiang W; Li M
    Inflammation; 2018 Oct; 41(5):1772-1779. PubMed ID: 29956068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.
    Cipolla E; Fisher AJ; Gu H; Mickler EA; Agarwal M; Wilke CA; Kim KK; Moore BB; Vittal R
    FASEB J; 2017 Dec; 31(12):5543-5556. PubMed ID: 28821630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis.
    Kato S; Inui N; Hakamata A; Suzuki Y; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Respir Res; 2018 Jun; 19(1):127. PubMed ID: 29940932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
    Skurikhin EG; Pershina OV; Reztsova AM; Ermakova NN; Khmelevskaya ES; Krupin VA; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Dygai AM
    PLoS One; 2015; 10(4):e0125065. PubMed ID: 25927611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
    Kimura T; Nojiri T; Hino J; Hosoda H; Miura K; Shintani Y; Inoue M; Zenitani M; Takabatake H; Miyazato M; Okumura M; Kangawa K
    Respir Res; 2016 Feb; 17():19. PubMed ID: 26895702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol.
    Judge JL; Nagel DJ; Owens KM; Rackow A; Phipps RP; Sime PJ; Kottmann RM
    PLoS One; 2018; 13(5):e0197936. PubMed ID: 29795645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.